325 related articles for article (PubMed ID: 34312700)
1. Keratin 7 expression in hepatic cholestatic diseases.
Sakellariou S; Michaelides C; Voulgaris T; Vlachogiannakos J; Manesis E; Tiniakos DG; Delladetsima I
Virchows Arch; 2021 Oct; 479(4):815-824. PubMed ID: 34312700
[TBL] [Abstract][Full Text] [Related]
2. Histopathology of cholestasis.
Desmet VJ
Verh Dtsch Ges Pathol; 1995; 79():233-40. PubMed ID: 8600686
[TBL] [Abstract][Full Text] [Related]
3. Comparative histologic features among liver biopsies with biliary-pattern injury and confirmed clinical diagnoses.
Yu S; Vidal B; Peric M; Rosenbaum MW; Cates JMM; Gonzalez RS
Hum Pathol; 2024 Apr; 146():8-14. PubMed ID: 38479481
[TBL] [Abstract][Full Text] [Related]
4. Chronic cholestasis detection by a novel tool: automated analysis of cytokeratin 7-stained liver specimens.
Sjöblom N; Boyd S; Manninen A; Knuuttila A; Blom S; Färkkilä M; Arola J
Diagn Pathol; 2021 May; 16(1):41. PubMed ID: 33957930
[TBL] [Abstract][Full Text] [Related]
5. Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis.
Sakisaka S; Kawaguchi T; Taniguchi E; Hanada S; Sasatomi K; Koga H; Harada M; Kimura R; Sata M; Sawada N; Mori M; Todo S; Kurohiji T
Hepatology; 2001 Jun; 33(6):1460-8. PubMed ID: 11391535
[TBL] [Abstract][Full Text] [Related]
6. Interlobular bile duct loss in pediatric cholestatic disease is associated with aberrant cytokeratin 7 expression by hepatocytes.
Ernst LM; Spinner NB; Piccoli DA; Mauger J; Russo P
Pediatr Dev Pathol; 2007; 10(5):383-90. PubMed ID: 17929991
[TBL] [Abstract][Full Text] [Related]
7. [Hepatic neoductules].
Fischer HP; Meybehm M; Zhou H; Schoch J
Verh Dtsch Ges Pathol; 1995; 79():36-46. PubMed ID: 8600693
[TBL] [Abstract][Full Text] [Related]
8. Loss of keratin 19 favours the development of cholestatic liver disease through decreased ductular reaction.
Chen Y; Guldiken N; Spurny M; Mohammed HH; Haybaeck J; Pollheimer MJ; Fickert P; Gassler N; Jeon MK; Trautwein C; Strnad P
J Pathol; 2015 Nov; 237(3):343-54. PubMed ID: 26108453
[TBL] [Abstract][Full Text] [Related]
9. Forkhead box A2 regulates biliary heterogeneity and senescence during cholestatic liver injury in mice‡.
McDaniel K; Meng F; Wu N; Sato K; Venter J; Bernuzzi F; Invernizzi P; Zhou T; Kyritsi K; Wan Y; Huang Q; Onori P; Francis H; Gaudio E; Glaser S; Alpini G
Hepatology; 2017 Feb; 65(2):544-559. PubMed ID: 27639079
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine features of reactive bile ductules in cholestatic liver disease.
Roskams T; van den Oord JJ; De Vos R; Desmet VJ
Am J Pathol; 1990 Nov; 137(5):1019-25. PubMed ID: 1700614
[TBL] [Abstract][Full Text] [Related]
11. Automated image analysis of keratin 7 staining can predict disease outcome in primary sclerosing cholangitis.
Sjöblom N; Boyd S; Manninen A; Blom S; Knuuttila A; Färkkilä M; Arola J
Hepatol Res; 2023 Apr; 53(4):322-333. PubMed ID: 36495019
[TBL] [Abstract][Full Text] [Related]
12. Hepatic NFAT signaling regulates the expression of inflammatory cytokines in cholestasis.
Cai SY; Yu D; Soroka CJ; Wang J; Boyer JL
J Hepatol; 2021 Mar; 74(3):550-559. PubMed ID: 33039404
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis.
Adams DH; Hubscher SG; Shaw J; Johnson GD; Babbs C; Rothlein R; Neuberger JM
Hepatology; 1991 Sep; 14(3):426-31. PubMed ID: 1714872
[TBL] [Abstract][Full Text] [Related]
14. Clusterin expression in cholestasis, hepatocellular carcinoma and liver fibrosis.
Aigelsreiter A; Janig E; Sostaric J; Pichler M; Unterthor D; Halasz J; Lackner C; Zatloukal K; Denk H
Histopathology; 2009 Apr; 54(5):561-70. PubMed ID: 19413638
[TBL] [Abstract][Full Text] [Related]
15. Cholangiocyte senescence in primary sclerosing cholangitis is associated with disease severity and prognosis.
Cazzagon N; Sarcognato S; Floreani A; Corrà G; De Martin S; Guzzardo V; Russo FP; Guido M
JHEP Rep; 2021 Jun; 3(3):100286. PubMed ID: 34041468
[TBL] [Abstract][Full Text] [Related]
16. ADAM Metalloproteinase Domain 17 Regulates Cholestasis-Associated Liver Injury and Sickness Behavior Development in Mice.
Almishri W; Swain LA; D'Mello C; Le TS; Urbanski SJ; Nguyen HH
Front Immunol; 2021; 12():779119. PubMed ID: 35095853
[TBL] [Abstract][Full Text] [Related]
17. Induction of Obstructive Cholestasis in Mice.
Weiskirchen R; Weiskirchen S; Tag CG; Meurer SK
Methods Mol Biol; 2023; 2669():163-175. PubMed ID: 37247059
[TBL] [Abstract][Full Text] [Related]
18. Human Hepatocellular response in Cholestatic Liver Diseases.
Ortiz K; Cetin Z; Sun Y; Hu Z; Kurihara T; Tafaleng EN; Florentino RM; Ostrowska A; Soto-Gutierrez A; Faccioli LAP
Organogenesis; 2023 Dec; 19(1):2247576. PubMed ID: 37598346
[TBL] [Abstract][Full Text] [Related]
19. Lack of concomitant expression of ICAM-1 and HLA-DR on bile duct cells from patients with primary sclerosing cholangitis and primary biliary cirrhosis.
Broomé U; Hultcrantz R; Scheynius A
Scand J Gastroenterol; 1993 Feb; 28(2):126-30. PubMed ID: 8095102
[TBL] [Abstract][Full Text] [Related]
20. Relationship between apoptosis, tumour necrosis factor, and cell proliferation in chronic cholestasis.
Floreani A; Guido M; Bortolami M; Della Zentil G; Venturi C; Pennelli N; Naccarato R
Dig Liver Dis; 2001 Oct; 33(7):570-5. PubMed ID: 11816546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
